1 Published with the approval of the Director of the Wisconsin Agricultural Experiment Station. Supported in part by research grants from the National Institutes of Health, U. S. Public Health Service (E-101). land mice was 64 mg per kg, but some mice were killed by 25 mg per kg.2 In each experiment a group of mice was injected with an equal volume of diluent containing polylysine in the absence of organisms to determine possible toxic reactions. All the animals which died during the course of the experiments were autopsied to be certain that death was due to the organism under investigation.
Salmonella typhimurium strain Iln. Slants of brucella agar (Albimi Laboratories, Inc., Brooklyn, N. Y.) were inoculated with bacteria taken from a typical colony. After an 18-hr incubation, the organisms were suspended in saline, serial 10-fold dilutions prepared in saline, and plate counts were made. The experiments on inhibition of infection were done by injecting intraperitoneally into salmonellae free Swiss white mice, 0.1 ml of the dilution of bacteria and immediately injecting intraperitoneally 0.2 ml polylysine or saline. Injections of polylysine or saline were given twice a day for the following 2 days and then once a day for 3 days. The animals were observed for 20 days. Table 1 shows that the animals treated with polylysine died more rapidly than the saline treated controls.
Type I pneumococcus. A 16-hr culture of type I pneumococcus grown in blood broth was used. The culture was serially diluted in 10-fold dilutions, using saline with 0.1 per cent peptone (Difco), and plate counts made on blood agar. The bacterial dilutions (0.5 ml) were injected intraperitoneally into each mouse (white Taconic strain) followed immediately by polylysine injected intraperitoneally. The experiment polylysine failed to give any protection when it was injected }f to Y hr before infection.
To determine the dose of polylysine needed to prevent infection with type I pneumococcus, each of the mice was injected with about three organisms, followed immediately by decreasing amounts of polylysine. All injections were by the intraperitoneal route. It can be seen in table 3 that an amount between 4 and 16 jig of polylysine per 20 g mouse was necessary for protection.
In order to determine whether polylysine would also protect against infection if it were injected at a different site than the inoculum, mice were injected intraperitoneally wvith type I pneumowith polylysine received 12 mg/kg coccus and the polylysine injected subcutaneously immediately after infection. There was no significant protection by polylysine against pneumococcal infection under these conditions. Also a series of rabbits was injected with pneumococci intradermally and the polylysine injected intraperitoneally. Polylysine did not protect the animals against the formation of large lesions due to the pneumococci.
Types II and III pneumococcus. Comparable experiments were done with these organisms, Bacillus anthracis. Anthrax spores were prepared by washing the growth from a 48-hr culture on nutrient agar slants with distilled water, heating the suspension in a water bath at 60 C for 1j/ hr, and then storing at -15 C until used. The appropriate dilutions (0.5 ml) of the spores in distilled water were injected intraperitoneally into Taconic strain mice which were immediately treated with polylysine intraperitoneally. Staphylococcus aureus. A strain of S. aureus which was penicillin sensitive and coagulase positive was used. Weanling mice weighing about 10 g when injected subcutaneously in the groin with 0.1 ml of an 18-hr culture of S. aureus develop a lesion which reaches its maximum size after about 1 week and then gradually heals. Groups of mice were treated topically with a 1 per cent solution of polylysine in saline or an ointment containing 10 per cent polylysine ;3 intraperitoneally with one injection of polylysine equivalent to 12 mg/kg body weight given before, at the same time, or several days after infection, or with multiple injections; or subcutaneously at the site of the infection at the same time as the infection or several days later. One group was inoculated with organisms which had been mixed with polylysine before infection. The last group and the group treated subcutaneously with polylysine at the time of the infection showed no evidence of infection, but all the others did.
DISCUSSION
As with the experiments using polylysine in vitro, these results indicate that the basic polypeptide, polylysine, affected the activity of certain pathogenic bacteria in vivo. There were differences in its effectiveness depending upoIn the type of organism studied and the route of injection of both the bacteria and polypeptide.
Polylysine was bacteriostatic in vitro to S.
typhimurium but significantly increased its pathogenicity for mice. No explanation for this enhancement of infection can be given. Mice infected with the pneumococci were protected by polylysine when both the infective agent and polylysine were injected intraperitoneally. There was no protection afforded when the type I pneumococci were injected intraperitoneally and polylysine subcutaneously in mice, or when rabbits were injected intradermally and treated intraperitoneally with polylysine. In vitro studies showed that polylysine was 3 Oil in water emulsion, prepared by adding 33. Experimental infections with S. aureus were inhibited by polylysine when it was mixed with the bacteria before infection or injected subcutaneously into the site of infection immediately after the infecting organisms. Topical applications or intraperitoneal injections of polylysine had no effect on the infection. Polylysine was bactericidal in vitro, but the results suggested that if applied topically or injected intraperitoneally it did not reach all of the infected site in a concentration sufficiently high to stop the growth of the bacteria. Also, the results may mean that the inhibitory effect of polylysine on the uptake by the phagocytes was reflected in the infection studies and explained the absence of effect. In contrast, salmine had some protective action on experimental infections of laboratory animals with staphylococcus (Negroni and Fischer, 1946) .
Polylysine was bactericidal to B. anthracis spores in vitro and had a significant protective effect against infections in mice when both the polylysine and spores were injected intraperitoneally. This mav have been due to a direct effect on the spores. Zwartouw and Smith (1956) showed that the extracellular acidic polypeptide had an antiphagocytic action which they believed to be due to the multivalent negative charge; the multivalent positive charge of polylysine might possibly enhance phagocytosis of the spores. A similar naturally occurring polypeptide-calf thymus histone-also protected mice when they were infected subcutaneously with spores and treated repeatedly with histone (Bloom et al., 1947) .
